Dendreon Pharmaceuticals  

Seal Beach,  CA 
United States
http://www.dendreon.com
  • Booth: 14130

Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cell therapy market. Dendreon’s flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells and has been prescribed to over 40,000 men with advanced prostate cancer in the U.S. since 2010. Dendreon is headquartered in Seal Beach, Calif. For more information, please visit www.dendreon.com.

 Products

  • PROVENGE® (sipuleucel-T) for mCRPC
    PROVENGE® (sipuleucel-T) is a prescription medicine used to treat certain men with advanced prostate cancer. Specifically, sipuleucel-T is an PROVENGE is an established cellular immunotherapy and is customized to each individual by using his own immune cells.  It is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone-refractory) prostate cancer.

    See the prescribing information.


     ...

Categories

Cancer Types
  • Genitourinary Cancer
  • Metastatic Disease
    • Categories:
  • Drug Development
  • Immunotherapy
  • Pharmaceutical
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined